CompanyProfileNomu
ActionsProfessional Medical Expertise Co.
- Nomu - Parallel Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 89.00
-
Open 87.80
-
High 90.20
-
Low 87.70
-
No. Of Trades 26
-
Avg. Trade size* 271
-
Volume Traded 7,036
-
Value Traded 630,382.30
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Trade Updates
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select A Maximum Of 5 Companies
LoginPortletPopupv2
ActionsAddtoWatchlistv2
ActionsAnnouncmentandCorporateAction
Actions- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
---|---|---|---|---|
05/11/2023 | 07/01/2024 | 25/01/2024 | Account Transfer | 2.85 |
CompanyProfileNomuv2Financials
Actions- Announcements & Corporate Actions
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Semi-Annual
Balance Sheet | ||||
---|---|---|---|---|
Total Assets | - | - | - | - |
Total Liabilities | - | - | - | - |
Total Shareholders Equity (After Deducting the Minority Equity) | - | - | - | - |
Total Liabilities and Shareholders Equity | - | - | - | - |
Statement of Income | ||||
Total Revenue (Sales/Operating) | - | - | - | - |
Net Profit (Loss) before Zakat and Tax | - | - | - | - |
Zakat and Income Tax | - | - | - | - |
Net Profit (Loss) after Zakat and Tax | - | - | - | - |
Total Comprehensive Income | - | - | - | - |
Profit (Loss) per Share | - | - | - | - |
Cash Flows | ||||
Net Cash From Operating Activities | - | - | - | - |
Net Cash From Investing Activities | - | - | - | - |
Net Cash From Financing Activities | - | - | - | - |
Cash and Cash Equivalents, Beginning of the Period | - | - | - | - |
Cash and Cash Equivalents, End of the Period | - | - | - | - |
All Figures in | ||||
All Currency In | ||||
Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
Balance Sheet | 2024-06-30 | |||
---|---|---|---|---|
Total Assets |
307,094.62
|
- | - | - |
Total Liabilities |
207,760.7
|
- | - | - |
Total Shareholders Equity (After Deducting the Minority Equity) |
99,335.11
|
- | - | - |
Total Liabilities and Shareholders Equity |
307,094.62
|
- | - | - |
Statement of Income | 2024-06-30 | |||
Total Revenue (Sales/Operating) |
149,432.65
|
- | - | - |
Net Profit (Loss) before Zakat and Tax |
13,508.43
|
- | - | - |
Zakat and Income Tax |
-1,400
|
- | - | - |
Net Profit (Loss) after Zakat and Tax |
12,108.43
|
- | - | - |
Total Comprehensive Income |
12,108.43
|
- | - | - |
Profit (Loss) per Share |
3.46
|
- | - | - |
Cash Flows | 2024-06-30 | |||
Net Cash From Operating Activities |
-12,430.12
|
- | - | - |
Net Cash From Investing Activities |
-3,692.94
|
- | - | - |
Net Cash From Financing Activities |
22,528.25
|
- | - | - |
Cash and Cash Equivalents, Beginning of the Period |
951.87
|
- | - | - |
Cash and Cash Equivalents, End of the Period |
7,357.06
|
- | - | - |
All Figures in | Thousands | |||
All Currency In | SAR | |||
Last Update Date | 2024-09-03 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
There are no investment limits on the company''s shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company''s bylaw and the issued Instructions by related regulators and supervisory authorities.
Company History
Professional Medical Expertise Company is a closed Saudi joint stock company established under Commercial Registration No. 2052001627 dated 14/08/1431H (corresponding to 26/07/2010G) issued in Dhahran, pursuant to Ministerial resolution No. 788 issued on 24/05/1443H (corresponding to 28/12/2021G). The Company''s current capital is thirty-five million Saudi Riyals (SAR 35,000,000) divided into three million five hundred thousand (3,500,000) ordinary shares paid in full, with a nominal value of ten Saudi Riyals (SAR 10) per share. The Company was established under the name of Socrates Specialized Trading Company by Ms. Nouf Ahmed Abdullah Al-Bassam and Mr. Nasser Mubarak Abdullah Al-Qahtani as a Saudi limited liability company, pursuant to the articles of association registered with the notary public at the Ministry of Commerce on 14/06/1430H (corresponding to 07/06/2009G) and Commercial Registration No. 2051040259 dated 24/06/1430H (corresponding to 18/06/2010G) issued from Al Khobar. On 05/05/1443H (corresponding to 09/12/2021G), the shareholders approved the conversion of the Company from a limited liability company to a (closed) joint stock company (closed) and on 24/05/1443H (corresponding to 28/12/2021G), the Ministry of Commerce issued resolution No. 788 approving the announcement of the Company''s conversion, and all procedures have been completed, including the amendment of the Commercial Register.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 35,000,000
- Issued Shares 3,500,000
- Paid Up Capital (SAR) 35,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2023-07-25
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Investors Relationship
Company Address:
Fluor Arabia Building, 7th Floor, Suite 702, Al Bandariyah, 34423 Al Khobar, Eastern Province, Saudi Arabia
Contact Details:
Telephone: 6997 857 (13) 966+
Fax: 7669 857 (13) 966+
Email: IR@PROMEDEX.COM
Company Website:
Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
---|---|---|---|---|
PROMEDEX MEDICAL EQUIPMENTS TRADING | 100.00% | Trading of medical and surgical devices and tools | United Arab Emirates | United Arab Emirates |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.